BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 19121388)

  • 1. Feasibility, stability and release performance of a time-dependent insulin delivery system intended for oral colon release.
    Maroni A; Del Curto MD; Serratoni M; Zema L; Foppoli A; Gazzaniga A; Sangalli ME
    Eur J Pharm Biopharm; 2009 May; 72(1):246-51. PubMed ID: 19121388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and evaluation of an oral delivery system for time-dependent colon release of insulin and selected protease inhibitor and absorption enhancer compounds.
    Del Curto MD; Maroni A; Foppoli A; Zema L; Gazzaniga A; Sangalli ME
    J Pharm Sci; 2009 Dec; 98(12):4661-9. PubMed ID: 19655371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability study of ambroxol hydrochloride sustained release pellets coated with acrylic polymer.
    Kibria G; Islam KM; Jalil RU
    Pak J Pharm Sci; 2009 Jan; 22(1):36-43. PubMed ID: 19168418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and evaluation of floating multi-layer coated tablets based on gas formation.
    Sungthongjeen S; Sriamornsak P; Puttipipatkhachorn S
    Eur J Pharm Biopharm; 2008 May; 69(1):255-63. PubMed ID: 17967527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Porous hydroxyapatite tablets as carriers for low-dosed drugs.
    Cosijns A; Vervaet C; Luyten J; Mullens S; Siepmann F; Van Hoorebeke L; Masschaele B; Cnudde V; Remon JP
    Eur J Pharm Biopharm; 2007 Sep; 67(2):498-506. PubMed ID: 17407810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug release behaviour from methyl methacrylate-starch matrix tablets: effect of polymer moisture content.
    Bravo-Osuna I; Ferrero C; Jiménez-Castellanos MR
    Eur J Pharm Biopharm; 2008 May; 69(1):285-93. PubMed ID: 17997292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different HPMC viscosity grades as coating agents for an oral time and/or site-controlled delivery system: a study on process parameters and in vitro performances.
    Sangalli ME; Maroni A; Foppoli A; Zema L; Giordano F; Gazzaniga A
    Eur J Pharm Sci; 2004 Aug; 22(5):469-76. PubMed ID: 15265517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, development and optimization of a novel time and pH-dependent colon targeted drug delivery system.
    Patel MM; Shah TJ; Amin AF; Shah NN
    Pharm Dev Technol; 2009; 14(1):62-9. PubMed ID: 18802844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and characterization of an oily-based system for oral delivery of insulin.
    Elsayed A; Remawi MA; Qinna N; Farouk A; Badwan A
    Eur J Pharm Biopharm; 2009 Oct; 73(2):269-79. PubMed ID: 19508890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and evaluation of mucinated sodium alginate microparticles for oral delivery of insulin.
    Builders PF; Kunle OO; Okpaku LC; Builders MI; Attama AA; Adikwu MU
    Eur J Pharm Biopharm; 2008 Nov; 70(3):777-83. PubMed ID: 18644444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preparation and examination of the vitro releasing of pH-dependent kuijiekang tablet for colon-specific delivery].
    Li RZ; Liao HW; Chen FY
    Zhong Yao Cai; 2007 Aug; 30(8):1025-7. PubMed ID: 18074860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel oral colon-targeting drug delivery system based on resistant starch acetate.
    Chen L; Pu H; Li X; Yu L
    J Control Release; 2011 Nov; 152 Suppl 1():e51-2. PubMed ID: 22195921
    [No Abstract]   [Full Text] [Related]  

  • 13. Development of time-, pH-, and enzyme-controlled colonic drug delivery using spray-dried chitosan acetate and hydroxypropyl methylcellulose.
    Nunthanid J; Huanbutta K; Luangtana-Anan M; Sriamornsak P; Limmatvapirat S; Puttipipatkhachorn S
    Eur J Pharm Biopharm; 2008 Feb; 68(2):253-9. PubMed ID: 17616377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compression coated systems for colonic delivery of 5-fluorouracil.
    Sinha VR; Singh A; Singh S; Bhinge JR
    J Pharm Pharmacol; 2007 Mar; 59(3):359-65. PubMed ID: 17331338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral delivery system for two-pulse colonic release of protein drugs and protease inhibitor/absorption enhancer compounds.
    Del Curto MD; Maroni A; Palugan L; Zema L; Gazzaniga A; Sangalli ME
    J Pharm Sci; 2011 Aug; 100(8):3251-3259. PubMed ID: 21465487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preparation of verapamil hydrochloride core-in-cup tablets with double-pulsatile and multi-phasic release].
    Li CJ; Zhu JB; Yu WY
    Yao Xue Xue Bao; 2008 Jun; 43(6):652-6. PubMed ID: 18822971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel poloxamers/hyaluronic acid in situ forming hydrogel for drug delivery: rheological, mucoadhesive and in vitro release properties.
    Mayol L; Quaglia F; Borzacchiello A; Ambrosio L; La Rotonda MI
    Eur J Pharm Biopharm; 2008 Sep; 70(1):199-206. PubMed ID: 18644705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colonic release and reduced intestinal tissue damage of coated tablets containing naproxen inclusion complex.
    Piao ZZ; Lee MK; Lee BJ
    Int J Pharm; 2008 Feb; 350(1-2):205-11. PubMed ID: 17928177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro evaluation of khaya and albizia gums as compression coatings for drug targeting to the colon.
    Odeku OA; Fell JT
    J Pharm Pharmacol; 2005 Feb; 57(2):163-8. PubMed ID: 15720778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality by design - Spray drying of insulin intended for inhalation.
    Maltesen MJ; Bjerregaard S; Hovgaard L; Havelund S; van de Weert M
    Eur J Pharm Biopharm; 2008 Nov; 70(3):828-38. PubMed ID: 18755270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.